Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains.
about
Chronic over-nutrition and dysregulation of GSK3 in diseasesInsulin Resistance and Endothelial Dysfunction Constitute a Common Therapeutic Target in Cardiometabolic DisordersAkt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)The critical role of Akt in cardiovascular functionEmerging methodologies to investigate lipid-protein interactionsEfficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft modelDevelopment of a human breast-cancer derived cell line stably expressing a bioluminescence resonance energy transfer (BRET)-based phosphatidyl inositol-3 phosphate (PIP3) biosensorCould the Ebola virus matrix protein VP40 be a drug target?The multifunctional Ebola virus VP40 matrix protein is a promising therapeutic target.Development of sulfonamide AKT PH domain inhibitors.Signal integration by lipid-mediated spatial cross talk between Ras nanoclustersPolyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer.Novel inhibitors of AKT: assessment of a different approach targeting the pleckstrin homology domain.Small-molecule inhibitors of the PI3K signaling networkMacrophage-activating lipopeptide-2 requires Mal and PI3K for efficient induction of heme oxygenase-1.Disulphide bridges of phospholipase C of Chlamydomonas reinhardtii modulates lipid interaction and dimer stabilityAkt Regulates TNFα synthesis downstream of RIP1 kinase activation during necroptosis.SGK3 mediates INPP4B-dependent PI3K signaling in breast cancerTargeting the PI3K/Akt/mTOR pathway in hepatocellular carcinoma.Optimization of the anti-cancer activity of phosphatidylinositol-3 kinase pathway inhibitor PITENIN-1: switching a thiourea with 1,2,3-triazoleA HPLC method for the quantitative determination of N-(2-hydroxy-5-nitrophenylcarbamothioyl)-3,5-dimethylbenzamide in biological samples.Immunomodulatory activity of a novel, synthetic beta-glucan (β-glu6) in murine macrophages and human peripheral blood mononuclear cells.Guidelines for visualizing and annotating rule-based modelsPhosphoinositide binding differentially regulates NHE1 Na+/H+ exchanger-dependent proximal tubule cell survivalRole of TAPP1 and TAPP2 adaptor binding to PtdIns(3,4)P2 in regulating insulin sensitivity defined by knock-in analysis.New Frontiers in DruggabilityInhibition of cell migration by PITENINs: the role of ARF6.Exploitation of the ability of γ-tocopherol to facilitate membrane co-localization of Akt and PHLPP1 to develop PHLPP1-targeted Akt inhibitors53BP1 suppresses tumor growth and promotes susceptibility to apoptosis of ovarian cancer cells through modulation of the Akt pathwayPhosphoinositide 3-kinase inhibitors induce DNA damage through nucleoside depletionAccurate prediction of the bound form of the Akt pleckstrin homology domain using normal mode analysis to explore structural flexibilityHigh-throughput fluorescence assay for membrane-protein interactionPPIP5K1 modulates ligand competition between diphosphoinositol polyphosphates and PtdIns(3,4,5)P3 for polyphosphoinositide-binding domains.Genetic inactivation or pharmacological inhibition of Pdk1 delays development and inhibits metastasis of Braf(V600E)::Pten(-/-) melanoma.Sirolimus and metformin synergistically inhibit hepatocellular carcinoma cell proliferation and improve long-term survival in patients with HCC related to hepatitis B virus induced cirrhosis after liver transplantation.AKT/GSK3β Signaling in Glioblastoma.PI3K/AKT/mTOR signaling pathway as a therapeutic target for ovarian cancer.Mice Deficient in lysophosphatidic acid acyltransferase delta (Lpaatδ)/acylglycerophosphate acyltransferase 4 (Agpat4) Have Impaired Learning and Memory.A protocol for the systematic and quantitative measurement of protein-lipid interactions using the liposome-microarray-based assay.Combination Nanopreparations of a Novel Proapoptotic Drug - NCL-240, TRAIL and siRNA.
P2860
Q26738964-4A76BAC8-E5BD-4E0B-876D-33A73AE01563Q26740443-6A7DAC4D-ECBA-40D7-B807-620D321EABDFQ28080599-7D46143E-A8C2-4890-8FEB-2289CF6AC35FQ28083829-E9939371-E140-4143-B603-EFCFB24C872BQ28386247-624A29E8-DD59-486B-9207-99A2423A69CAQ28482093-904E6A35-48CC-4629-B50A-A1B2F30DF975Q28541161-4861F2D2-5FB6-4EDE-B100-2C068AC15D36Q30356113-0484AA65-B0BE-4785-AE26-F0044C85EB8FQ30376138-7D4614CD-BAF5-4605-AD0D-EAFC1113AAF8Q30500090-21AD1DB9-10F3-4253-9272-B60477EF0658Q33623159-BEA7DD33-DD74-4BDD-9D92-FF07221B98B3Q33761889-5FE60705-70CB-4232-B160-E0AED450D527Q33882138-E2025303-79CF-429E-8B29-E01969669B9BQ33883982-661E3D5A-4491-433A-B41B-383F9EE04030Q33982787-F8B0E717-6090-4550-8C56-0E8BA2C9FB26Q34318407-A91F0F09-493C-440F-B913-4F8C43C17653Q34612975-21488D6F-2DF0-4454-8547-5CED68B9B65CQ34629544-4D70059E-9776-4B7C-9867-25189DD36D09Q34632966-64DBCFA6-EFCB-4123-9439-7F8F106EDBAEQ34653200-D29C0910-B002-4DB1-AD7C-1F411BDAA594Q34988900-AB99368D-D52D-4977-BB09-6823B2554E47Q35040422-DCEEAB15-4619-41B5-9A9D-D512ACDC8E89Q35201519-229469BD-F4B6-464A-8705-3ADA3ED6E82BQ35604890-0C656B6C-FD6D-4D28-A392-7B9E9811727CQ35707657-3CFB5B2F-1947-402A-B72D-29DDF2E69D52Q35730955-27B29465-4933-4AF2-B3A3-107E0B96166DQ35848465-44445F49-7674-4957-B07E-947DBB0AF18DQ36482696-FB166553-7A18-4B4A-965A-BA9B7708383CQ36642343-040342D0-BE10-4632-A993-2AE1C7FF85CDQ37142812-C007B3D8-C9DC-4901-B50A-E7CA6F2CE895Q37253674-A4EED4EC-079B-4BDC-90E0-31EF7F8A0A20Q37305439-8AB470FB-BC79-4D5B-B0DF-C68EFDC670CCQ37596231-2C994241-8DDF-4E53-89D8-6A99E8A8087BQ37640041-C247F2BE-05A7-4865-B611-3DDAA6F61E9FQ37641827-087989EE-C9DA-412A-BD2E-2E23DA82EEF6Q37710163-F5849678-113B-470A-9E50-09FE75CA81FEQ38236320-75EEBD6A-8E74-4B75-BAF6-C81779929937Q38625051-FB7FD433-B784-44ED-9708-45770512F269Q38773049-AC4B0A08-53F4-4E9E-B8D0-55D82C8D0D6BQ38788181-420D43A0-954B-4BA4-B432-D143B63DC9C5
P2860
Small molecule inhibition of phosphatidylinositol-3,4,5-triphosphate (PIP3) binding to pleckstrin homology domains.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Small molecule inhibition of p ...... o pleckstrin homology domains.
@ast
Small molecule inhibition of p ...... o pleckstrin homology domains.
@en
type
label
Small molecule inhibition of p ...... o pleckstrin homology domains.
@ast
Small molecule inhibition of p ...... o pleckstrin homology domains.
@en
prefLabel
Small molecule inhibition of p ...... o pleckstrin homology domains.
@ast
Small molecule inhibition of p ...... o pleckstrin homology domains.
@en
P2093
P2860
P356
P1476
Small molecule inhibition of p ...... o pleckstrin homology domains.
@en
P2093
Alexey Lugovskoy
Benchun Miao
Brian Schaffhausen
C V Ramana
Gerhard Wagner
Igor Skidan
Jenny Maki
Jinsheng Yang
Junying Yuan
P2860
P304
20126-20131
P356
10.1073/PNAS.1004522107
P577
2010-11-01T00:00:00Z